Understand the source comparison
Best Cerebrolysin for Stroke Recovery: Research-Grade Comparison
Not all Cerebrolysin sources meet research standards. The table below compares key quality markers across peptide grades commonly encountered in stroke recovery research. Peptide Purity ≥98% via HPLC, batch-verified 85–95%, inconsistent documentation ≥99%, GMP
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Not all Cerebrolysin sources meet research standards. The table below compares key quality markers across peptide grades commonly encountered in stroke recovery research.
- Peptide Purity
- ≥98% via HPLC, batch-verified
- 85–95%, inconsistent documentation
- ≥99%, GMP-certified
- Research-grade offers the best balance of verified purity and accessibility for laboratory studies
- Molecular Weight Distribution
- 1,000–10,000 Da, mass spectrometry confirmed
- Unverified or supplier-certified only
- 1,000–10,000 Da, regulatory-grade testing
- Clinical-grade verification is gold standard; research-grade provides equivalent data at lower cost
- Endotoxin Testing
- <0.5 EU/mL per batch (USP <85>)
- Often untested or >1.0 EU/mL
- <0.25 EU/mL, release-tested
- Endotoxin contamination invalidates neuroprotection studies. Testing is non-negotiable
- Amino Acid Sequencing
- Exact sequence verification per batch
- Not provided
- Full sequence validation
- Sequence verification prevents cross-contamination and confirms bioactive peptide identity
- Third-Party CoA
- Provided with HPLC, MS, sterility data
- Rarely available
- Provided with full regulatory documentation
- Independent verification separates research-grade quality from marketing claims
- Storage & Handling Documentation
- Detailed stability data, temperature logs
- Generic guidance only
- Full stability program per ICH guidelines
- Proper storage prevents peptide degradation that compromises experimental reproducibility